YONGHE MEDICAL (02279) announced its interim results for the six months ended June 30, 2025. The group achieved revenue of RMB 862 million, gross profit of RMB 550 million representing a 3.9% year-over-year increase, and profit attributable to shareholders of RMB 27.913 million, marking a turnaround from loss to profit. Earnings per share reached RMB 0.06.

As China's leading medical group specializing in hair medical services, the company provides comprehensive one-stop hair medical services covering hair transplantation, medical hair care, routine maintenance, and other supporting services. The company has consistently focused on the hair medical services market and established a full industry chain brand portfolio centered on "YONGHE MEDICAL," comprising professional hair transplant brand "Yonghe Hair Transplant," medical hair care brand "Syunson," women's aesthetic hair transplant brand "Yonghe Hair Beginning," and medical wig brand "Hafada."

As of June 30, 2025, the company operates 63 hair transplant medical institutions across 61 cities nationwide and maintains 6 Syunson hair health facilities in Shenzhen, Shanghai, and Guangzhou, making it China's largest chain hair medical group with the most extensive city coverage. During the six months ended June 30, 2025, the company served a total of 64,845 consumers.